Welcome to our dedicated page for MITESCO news (Ticker: MITI), a resource for investors and traders seeking the latest updates and insights on MITESCO stock.
Mitesco, Inc. (symbol: MITI) is a development stage company dedicated to consolidating businesses within the compound pharmacy industry, serving human and veterinary markets. Beginning its operations in the Southeast, Mitesco aims to acquire compounders across the United States that align with its mission and vision. The company is committed to unlocking the potential of the compounding pharmacy sector to improve both human and animal health, meet unmet patient needs, enhance the dignity of skilled pharmacists, and build shareholder value through providing quality, cost-effective, and innovative healthcare products and pharmaceuticals worldwide.
Mission: To unlock the potential of the compounding pharmacy industry, improve health outcomes, and provide innovative healthcare solutions while building shareholder value.
Vision: To be globally recognized for best practices in quality, efficiency, and sustainability within the compounding pharmaceutical industry.
Recent Achievements & Current Projects:
- Full compliance with reporting requirements, including the completion of the Annual Report on Form 10-K.
- Engagement of Accell Group as their auditor to support compliance and review records effectively.
- Institutional investors' continued support through 12-month notes to secure funding needs.
- Ongoing evaluation of the company's capital structure to support both historical and new investors.
- Formation of a new Advisory Board to assist in evaluating potential acquisition candidates, including both private and publicly held entities.
- Strategic focus on technology, service, and product business candidates, with a view towards distributing dividends to shareholders from spin-outs.
Financial Condition: Mitesco is actively managing its financial structure, including the termination of a prior stock option program, cancellation of a reverse stock split, and adjustment of restricted stock dividends to protect common stockholders' interests.
Partnerships: Collaboration with Accell Group and support from institutional investors have been crucial in advancing Mitesco's key initiatives and compliance activities.
Future Prospects: With a strategy focused on both organic and acquisition growth, Mitesco aims to leverage its expertise in startups and turnarounds to create successful growth situations. The company is also exploring new initiatives in the data center market and cyber security services, intending to enter commercial, governmental, and utility markets.
Conclusion: Mitesco's dedication to providing high-quality, accessible, and affordable healthcare solutions underscores its potential to become a leading player in the compounding pharmacy industry. By focusing on quality, efficiency, and sustainability, Mitesco is positioned for long-term growth and shareholder value creation.
Mitesco, Inc. (OTCQB: MITI) is expanding its operations in the Twin Cities with a new The Good Clinic location in St. Louis Park, MN, set to open in late August to early September 2021. This site will focus on comprehensive, personalized primary care. CEO Michael Howe emphasized the clinic's commitment to wellness and community engagement. The company plans to establish six additional clinics in the greater metropolitan area, utilizing cutting-edge telehealth technology and nurse practitioners as primary care providers.
Mitesco, Inc. (OTCQB: MITI) has appointed Tom Brodmerkel as the new Chairman of the Board, marking a strategic shift towards expansion for its wellness clinic operations. Former Chairman Ronald Riewold will retire but remain as a strategic advisor, focusing on acquisitions. Brodmerkel brings extensive experience in healthcare services, previously working with United Healthcare and Coventry Health Care. This leadership change aims to enhance the rollout of The Good Clinic and leverage market opportunities for growth in a preventive care model.
Mitesco, Inc. (OTCQB: MITI), a wellness clinic operator, will present at the Q2 Virtual Investor Summit on May 17, 2021. CEO Larry Diamond is set for one-on-one meetings with investors and will host a virtual presentation at 1:15 p.m. Eastern time. Registration is mandatory to participate. The Good Clinic, a subsidiary, plans to establish a telehealth network of clinics, starting in Minneapolis, and aims for nationwide expansion. Mitesco also has future operations in Europe through its subsidiary, Acelerar Healthcare Holdings, based in Dublin.
Mitesco, Inc. (OTCQB: MITI) has announced its participation in the upcoming Planet MicroCap Showcase, taking place virtually from April 20-22, 2021. CEO Larry Diamond will engage in one-on-one meetings and present on April 22 at 9:00 a.m. Eastern time. The event will feature a range of presentations and educational panels from promising companies. Mitesco operates wellness clinics powered by technology and customized care plans, aiming to expand its clinic network nationwide through its subsidiary, The Good Clinic.
Mitesco, Inc. (OTCQB: MITI) has appointed Ms. Jenny Lindstrom as Chief Legal Officer and Secretary. Her extensive experience in real estate, employment law, litigation, and securities law positions her well for Mitesco's expansion goals beyond North America. CEO Larry Diamond emphasized Lindstrom's qualifications to manage leases and legal matters critical for their up-listing initiative. Lindstrom previously served as General Counsel for Radisson Hospitality and has a Juris Doctor from the University of Minnesota. Mitesco plans to enhance its wellness clinic network using advanced telehealth technology.
Mitesco, Inc. (OTCQB: MITI) has engaged MZ Group for a strategic investor relations and communications program. This initiative aims to enhance visibility and promote its health clinics and telehealth services, utilizing nurse practitioners for personalized care. Mitesco has opened its first clinic, The Good Clinic, in Minneapolis and plans to establish 5 to 7 additional clinics this year. The company's innovative model shows promise for better patient outcomes, reduced costs, and increased revenue. Mitesco is also targeting acquisitions to support its expansion and enhance service offerings in healthcare technology.
Mitesco, Inc. (OTCQB: MITI) has appointed Mr. Phillip Keller as its new Chief Financial Officer. With over 30 years of finance and accounting experience, including significant international exposure, Keller is expected to aid Mitesco's plans for expansion and potential uplisting to a major exchange. Keller expressed enthusiasm for enhancing healthcare delivery through Mitesco's subsidiaries, The Good Clinic and Acelerar Healthcare. The Good Clinic aims to establish a nationwide telehealth network, beginning in Minneapolis, leveraging a nurse practitioner model.
The Good Clinic has opened in Northeast Minneapolis, offering a new approach to health care that emphasizes wellness and patient relationships. Founded by former Minute Clinic leaders, it aims to empower patients and provide personalized care. Services include primary care, behavioral wellness, chronic disease management, and more. The clinic accepts major Minnesota insurance and plans to expand its locations nationwide. CEO Michael Howe highlights the focus on integrated care to improve overall wellbeing.
Mitesco Inc. (OTCQB: MITI) is set to present at the Emerging Growth Conference on February 17, 2021. The event offers investors a real-time opportunity to engage with CEO Mr. Larry Diamond, who will discuss new corporate actions, strategic plans for The Good ClinicTM, and potential expansions. The presentation is scheduled for 12:30 PM Eastern and will last 30 minutes. Attendees can register online, and a recorded version will be available post-event. Mitesco aims to enhance healthcare delivery through innovative technologies.
FAQ
What is the current stock price of MITESCO (MITI)?
What is the market cap of MITESCO (MITI)?
What does Mitesco, Inc. do?
Where is Mitesco, Inc. starting its operations?
What is Mitesco's mission?
Who is Mitesco's new auditor?
What recent financial adjustments has Mitesco made?
What will Mitesco's new Advisory Board focus on?
What new market is Mitesco exploring?
How is Mitesco managing its capital structure?
What is Mitesco's vision?
Who supports Mitesco financially?
